RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat head and neck cancers
Disease control Not yet recruitingThis study is testing a combination of three drugs (docetaxel, nimotuzumab, and pucotenlimab) for people with advanced head and neck cancer that has returned or spread after previous treatments. The goal is to see if this new combination can help control the cancer and improve su…
Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Scientists test 'Smart Bomb' drug to fight tough head and neck cancers
Disease control Not yet recruitingThis study is testing a new type of targeted cancer drug, GSK5764227, for people with advanced head and neck cancer that has returned or spread. The drug works like a 'smart bomb' that seeks out cancer cells and delivers a chemotherapy agent directly to them. Researchers will giv…
Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC